Investment
Feds and OmniaBio partner to expand Hamilton facility for revolutionary cell and gene therapies
The Government of Canada announced a collaboration with OmniaBio to expand its facility at McMaster Innovation Park. This expansion will focus on manufacturing cell and gene therapies, providing production services globally, and strengthening Canada's role in global value chains. The project aims to revolutionize treatments for chronic diseases such as cancer, autoimmune conditions, diabetes, cardiovascular, and neurological diseases.
Apr 3, 2025